Immediate Impact
5 by Nobel laureates 6 from Science/Nature 65 standout
Citing Papers
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
2022 Standout
Works of Nancy L. Samberg being referenced
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies
2016
The α3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation
1989
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Nancy L. Samberg | 74 | 30 | 68 | 37 | 15 | 163 | ||
| Kirsi J. Rautajoki | 93 | 35 | 1 | 89 | 12 | 13 | 200 | |
| Kristin Fino | 91 | 95 | 3 | 47 | 33 | 16 | 208 | |
| Zhengping Wei | 83 | 48 | 1 | 80 | 25 | 11 | 197 | |
| Metin Yusuf Gelmez | 128 | 21 | 1 | 46 | 17 | 17 | 209 | |
| Valery Volk | 60 | 69 | 1 | 39 | 26 | 12 | 148 | |
| T.O. Bleiker | 83 | 32 | 51 | 24 | 10 | 201 | ||
| Yasutaka Okita | 35 | 34 | 4 | 55 | 21 | 20 | 140 | |
| Hao Zeng | 31 | 53 | 1 | 71 | 34 | 19 | 177 | |
| Jingjing Gong | 47 | 54 | 3 | 51 | 20 | 16 | 151 | |
| Stephen Harper | 30 | 46 | 96 | 15 | 12 | 153 |
All Works
Loading papers...